ee Figure 2

Text page 736: "Survival of Ptc1+/- Mice after Neonatal Exposure to RF EMF Radiation The tumor-free survival of wild-type and Ptc1+/- mice and the relative survival data are shown in Fig. 2. The survival curves for the total groups and separate curves for males and females are shown in Fig. 2A, B and C, respectively. Due to their tumor predisposition, Ptc1/ mice survived for a significantly shorter time than their wild-type siblings regardless of RF-radiation exposure (logrank P value 0.0001). The curves in each graph are clearly clustered in two groups that separate the Ptc1+/+ from the Ptc1+/- genotypes. The survival data for Ptc1+/- and Ptc1+/+ mice are summarized in Fig. 2D. No significant reduction in mean survival was observed in total groups of Ptc1+/- mice exposed as newborns to RF EMFs compared to sham-exposed mice (46 22 weeks compared to 48 28 weeks). Although analysis of both sexes showed a trend toward increased mean survival of exposed Ptc1+/- male mice compared to females (50 23 weeks compared to 43 21 weeks), logrank tests showed that these differences were not statistically significant. The mean survival of sham-exposed Ptc1+/- males and females was very similar (49 33 weeks and 48 24 weeks, respectively). Thus no obvious interaction between RF-field exposure and sex was detected in our experimental conditions. Sham-irradiated Ptc1+/+ mice had a mean survival time of 100 24 weeks, which was not significantly different from the 95 33 weeks for mice exposed to RF radiation. In addition, no significant difference in survival was observed between Ptc1+/+ males and females in both the sham-exposed and exposed groups."

Ptc1+/+ mice, combined

HAWC